CVS Health reaffirms $7–$7.20 EPS target for 2026 while advancing cost-based pharmacy model

CVS Health reaffirmed its guidance for full year 2026 revenue of at least $400 billion and adjusted EPS in the range of $7 to $7.20. Newman commented, "We are encouraged by the strength of our results ...
24/7 Wall St.

This Overlooked Dividend Sector Is Beating Inflation Better Than Bonds

The Enterprise Product Partners business model is fee-based, which keeps revenue predictable and supports the dividend even when energy markets are choppy. Dividend growth of 3.57% isn’t flashy, but ...

Harbor SMID Cap Value ETF Q4 2025 Performance Review

Timken remains a compelling investment as it supplies essential components that customers cannot easily replace. Read more ...

ECONOCOM: 2025 full-year results - Solid performance despite a challenging environment and progress on the group's transformation as part of the One Econocom plan

Press release REGULATED INFORMATION Brussels, 10 February 2026 2025 full-year results - Solid performance despite a challenging environment and progress on the group's transformation as part of the ...